AI assistant
Sending…
X4 Pharmaceuticals, Inc — Director's Dealing 2020
Nov 3, 2020
34355_dirs_2020-11-03_8b0fafc9-349e-41c3-a3a1-d7396b0da06e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2020-11-02
Reporting Person: Taveras Arthur (Chief Scientific Officer)
More from X4 Pharmaceuticals, Inc
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 20
Regulatory Filings
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17